Fig. 2: Turnaround time of WGS-based cancer genome profiling in the clinical setting. | Experimental & Molecular Medicine

Fig. 2: Turnaround time of WGS-based cancer genome profiling in the clinical setting.

From: Clinical application of whole-genome sequencing of solid tumors for precision oncology

Fig. 2

TAT was measured as working days from sample collection to the acquisition of the WGS report. The processes of the WGS assay were subdivided into six components: (1) library preparation, (2) presequencing quality assessment and library pooling, (3) sequence production, (4) postsequencing process, (5) bioinformatics analysis, and (6) final curation/report generation.

Back to article page